Issuer Information

EDGAR: Contact Information
  • Name:
    Kalytera Therapeutics, Inc.
  • Address:
    4040 CIVIC CENTER DRIVE, SUITE 200
    SAN RAFAEL, CALIFORNIA 94903
  • Phone:
    888-861-2008
EDGAR: Other Information
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Entity Type:
    Corporation
  • Incorporated:
    Within 5 years (2016)
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
322312: 0001639643-19-000004
First Sale: 2019-09-13
Security Type(s): Equity
Offer Amount: $2,407,562
Amount Sold: $760,000
Remaining: $1,647,562
06c

CA, KY, NJ,

303763: 0001639643-19-000003
First Sale: 2019-01-22
Security Type(s): Equity
Offer Amount: $338,333
Amount Sold: $145,000
Remaining: $193,333
06b

CA,

303756: 0001639643-19-000002
First Sale: 2019-01-15
Security Type(s): Equity
Offer Amount: $1,050,000
Amount Sold: $450,000
Remaining: $600,000
06b

NJ,

254018: 0001639643-18-000003
First Sale: 2017-12-20
Security Type(s): Units (convertible debentures and warrants to purchase common shares)
Offer Amount: $200,000
Amount Sold: $200,000
06b No Notices in EFD for this offering.
169952: 0001639643-16-000004
First Sale: 2016-07-19
Security Type(s): Equity
Offer Amount: $2,400,000
Amount Sold: $250,750
Remaining: $2,149,250
06b No Notices in EFD for this offering.
140318: 0001639643-15-000003
First Sale: 2014-07-29
Security Type(s): Equity
Offer Amount: $100,000
Amount Sold: $100,000
05, 06b, 4a5 No Notices in EFD for this offering.
140316: 0001639643-15-000002
First Sale: 2015-03-19
Security Type(s): Equity
Offer Amount: $200,000
Amount Sold: $200,000
05, 06b, 4a5 No Notices in EFD for this offering.
140315: 0001639643-15-000001
First Sale: 2014-12-23
Security Type(s): Equity
Offer Amount: $100,000
Amount Sold: $100,000
05, 06b, 4a5 No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.